Key architectural changes in tumor-negative lymph nodes from metastatic-free oral cancer patients are valuable prognostic factors

Clinical and Experimental Metastasis

Volumn 31, Issue 3, 2014, Pages 327-338

  Vered, Marilena ^a,b   Schiby, Ginette ^a   Schnaiderman Shapiro, Anna ^b   Novikov, Ilya ^c   Bello, Ibrahim O ^d   Salo, Tuula ^d   Rytkönen, Aleksi ^d   Kauppila, Joonas H ^e   Dobriyan, Alex ^a   Yahalom, Ran ^a   Taicher, Shlomo ^a   Dayan, Dan ^b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c GERTNER INSTITUTE FOR EPIDEMIOLOGY AND HEALTH POLICY RESEARCH   (Israel)

^d OULU UNIVERSITY HOSPITAL   (Finland)

^e UNIVERSITY OF OULU   (Finland)

Author keywords

Capsule thickness; Neck negative; Oral cancer; Prognosis; Reactive follicles; Tumor negative lymph nodes

Indexed keywords

ADULT; ARTICLE; CANCER MORTALITY; CANCER PATIENT; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; DISEASE SPECIFIC SURVIVAL; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPH NODE BIOPSY; MAJOR CLINICAL STUDY; MALE; MOUTH CANCER; NECK DISSECTION; OUTCOME ASSESSMENT; SCORING SYSTEM; SINUS VENOSUS; AGED; GENETICS; LYMPH NODE METASTASIS; MIDDLE AGED; MORTALITY; MOUTH TUMOR; PATHOLOGY; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; TREATMENT OUTCOME;

ADULT; AGED; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; TREATMENT OUTCOME;

EID: 84897577794     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-013-9631-4     Document Type: Article

References (27)

1. Johnson NW, Warnakulasuriya S, Gupta PC et al (2011) Global oral health inequalities in incidence and outcomes for oral cancer: causes and solutions. Adv Dent Res 23:237-246
2. Silverman S Jr, Lee N, Kramer AM et al (2003) Spread of tumor, staging and survival. In: Silverman S Jr (ed) Oral cancer, 5th edn. New York, Decker, pp 81-94
3. Patel V, Marsh CA, Dorsam RT et al (2011) Decreased lymphangiogenesis and lymph node metastasis by mTOR inhibition in head and neck cancer. Cancer Res 71:7103-7114
4. Sleeman J, Schmid A, Thiele W (2009) Tumor lymphatics. Semin Cancer Biol 19:285-297
5. Coghlin C, Murray GI (2010) Current and emerging concepts in tumour metastasis. J Pathol 222:1-15
6. Psaila B, Lyden D (2009) The metastatic niche: adapting the foreign soil. Nat Rev Cancer 9:285-293
7. Da MX, Wu Z, Tian HW (2008) Tumor lymphangiogenesis and lymphangiogenic growth factors. Arch Med Res 39:365-372
8. Lee AS, Kim DH, Lee JE et al (2011) Erythropoietin induces lymph node lymphangiogenesis and lymph node tumor metastasis. Cancer Res 71:4506-4517
9. Qian CN, Berghuis B, Tsarfaty G et al (2006) Preparing the "Soil": the primary tumor induces vasculature reorganization in the sentinel lymph node before the arrival of metastatic cancer cells. Cancer Res 66:10365-10376 (Pubitemid 44799756)
10. Mayorca-Guiliani AE, Yano H, Nakashiro K, Hamakawa H, Tanaka J (2012) Premetastatic vasculogenesis in oral squamous cell carcinoma xenograft-draining lymph nodes. Oral Oncol 48:663-670
11. Berlinger NT, Tsakraklides V, Pollak K, Adams GL, Yang M, Good RA (1976) Immunologic assessment of regional lymph node histology in relation to survival in head and neck carcinoma. Cancer 37:697-705
12. Brandwein-Gensler M, Teixeira MS, Lewis CM et al (2005) Oral squamous cell carcinoma: histologic risk assessment, but not margin status, is strongly predictive of local disease-free and overall survival. Am J Surg Pathol 29:167-178 (Pubitemid 40170634)
13. Bello IO, Vered M, Dayan D et al (2011) Cancer-associated fibroblasts, a parameter of the tumor microenvironment, overcomes carcinoma-associated parameters in the prognosis of patients with mobile tongue cancer. Oral Oncol 47:33-38
14. Elmore SA (2006) Enhanced histopathology of the lymph nodes. Toxicol Pathol 34:634-647
15. Elmore SA (2006) Histopathology of the lymph nodes. Toxicol Pathol 34:425-454
16. Willards-Mack CL (2006) Normal structure, function and histology of lymph nodes. Toxicol Pathol 34:409-424
17. Huang SF, Kang CJ, Lin CY et al (2008) Neck treatment of patients with early stage oral tongue cancer: comparison between observation, supraomohyoid dissection, and extended dissection. Cancer 112:1066-1075
18. Iype EM, Sebastian P, Mathew A, Balagopal PG, Varghese BT, Thomas S (2008) The role of selective neck dissection (I-III) in the treatment of node negative (N0) neck in oral cancer. Oral Oncol 44:1134-1138
19. Ferlito A, Rinaldo A, Silver CE et al (2006) Elective and therapeutic selective neck dissection. Oral Oncol 42:14-25 (Pubitemid 41831517)
20. Byers RM, Weber RS, Andrews T et al (1997) Frequency and therapeutic implications of "skip metastases" in the neck from squamous carcinoma of the oral tongue. Head Neck 19:14-19 (Pubitemid 26425084)
21. Miliauskas JR, Leong AS (1991) Localized herpes simplex lymphadenitis: report of three cases and review of the literature. Histopathology 19:355-360
22. De Wever O, Mareel M (2003) Role of tissue stroma in cancer cell invasion. J Pathol 200:429-447 (Pubitemid 36818244)
23. Barkan D, El Touny LH, Michalowski AM et al (2010) Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. Cancer Res 70:5706-5716
24. Conlin MW, Eickhoff JC, Riching KM et al (2011) Aligned collagen is a prognostic signature survival in human breast carcinoma. Am J Pathol 178(1221-1232):24
25. Cox TR, Bird D, Baker AM, Barker HE, Ho MW, Lang G, Erler JT (2013) LOX-mediated collagen crosslinking is responsible for fibrosis-enhanced metastasis. Cancer Res. doi:10.1158/0008-5472.CAN-12-2233
26. Wang MB, Lichtenstein A, Mickel RA (1991) Hierarchical immunosuppression of regional lymph nodes in patients with head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 105:517-527
27. Jewett A, Head C, Cacalano NA (2006) Emerging mechanisms of immunosuppression in oral cancers. J Dent Res 85:1061-1073 (Pubitemid 44935523)